Updated Oct 27, 2026 · 09:24 UTC

MRKMerck & Co Inc

Health Care · United States · XNYS · pharmaceutical preparations
$141.22−3.21%last session · market early-hours
Market cap
$348.31b
real-world
Tokenized
$214k
<0.001% of the asset
Avg token price
$143.01
+1.27% vs real
Spot volume, 24h
$173k
5 venues
Derivatives, 24h
$2.7m
0.2% of real volume
Perp open interest
$1.9m
20 venues
In DeFi
—
MRK · Price
Token Real

EarningsNasdaq’s earnings calendar

Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $2.12 (5 analysts)
Last earnings, Aug 4
−$0.13 EPS
+50.0% vs −$0.26 forecast · Jun 2026 quarter

Real marketMerck & Co., Inc.

Last close
$145.27
Oct 23
Traded on Oct 23
$1.21b
Price now
$141.22
market early-hours

Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals

Spot · $173k · 5 venues
Blynex1 pair$173k
Uniswap v3 (X Layer)1 pair$141
Kraken1 pair$93
Derivatives · $2.7m · 20 venues · $1.9m open interest
BingX1 pair · OI $834k · funding +0.0050%$1.2m
Ourbit1 pair · OI $20k · funding +0.0000%$367k
Binance1 pair · OI $121k · funding +0.0000%$252k

In DeFiPools and lending markets that hold these tokens

None found

Onchain versions3 tokens from 2 issuers

MRKXBacked Assets$143.00$196k
MRKonOndo Assets$143.05$16k
WMRKXBacked Assets$140.33$2k

HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain

Solana148 holders$181k
BNB Chain80 holders$3k
Ethereum59 holders$21k
X Layer12 holders$2k
Ink7 holders$8k
TON5 holders$9k
Arbitrum— holders$0

Business 12 months to Jun 2026 · SEC EDGAR

Results
Revenue
$66.57b
+5% YoY
Net income
$3.17b
5% margin · −81% YoY
EPS, diluted
$1.28
−80% YoY
Diluted shares
2.47b
−2% YoY
Cash and balance sheet
Free cash flow
$16.06b
24% of revenue · 4.6% yield
Net debt
$45.54b
$8.36b cash and securities, $53.91b debt
10-Q filed Aug 7, 2026 ↗

Quarterly

Sep '24Jun '26
RevenueNet income
Valuation today’s market cap $348.31b · enterprise value $393.86b
P/E
110×
EV / sales
5.9×